- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 5/037 - Peptides having up to four amino acids in a fully defined sequenceDerivatives thereof containing at least one abnormal peptide link the abnormal link being formed by the side chain of an alpha-amino acid, e.g. gamma-Glu, epsilon-Lys, glutathione
Patent holdings for IPC class C07K 5/037
Total number of patents in this class: 93
10-year publication summary
3
|
6
|
4
|
7
|
2
|
5
|
2
|
5
|
3
|
2
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Kyowa Hakko Bio Co., Ltd. | 306 |
13 |
Apotex Technologies Inc. | 16 |
7 |
Kaneka Corporation | 4544 |
3 |
Centre National de La Recherche Scientifique | 10465 |
2 |
Ajinomoto Co., Inc. | 2294 |
2 |
Provincial Health Services Authority | 185 |
2 |
The University of British Columbia | 1497 |
2 |
The University of Queensland | 662 |
2 |
Fusion Pharmaceuticals Inc. | 86 |
2 |
Obschestvo S Ogranichennoi Otvetstvennostiyu "z Therapeutics" | 3 |
2 |
Next Level Health Sciences Inc. | 12 |
2 |
The Regents of the University of California | 19989 |
1 |
Janssen Pharmaceutica N.V. | 3377 |
1 |
Bayer Pharma AG | 1052 |
1 |
Novozymes A/S | 3325 |
1 |
Purdue Research Foundation | 3638 |
1 |
Beijing Molecule Science and Technology Co., Ltd. | 12 |
1 |
Beijing Normal University | 95 |
1 |
CARA Therapeutics, Inc. | 49 |
1 |
Chengdu University of Technology | 123 |
1 |
Other owners | 45 |